Real-world outcomes for lisocabtagene maraleucel in patients with relapsed or refractory large B-cell lymphoma. Crombie JL, Ahmed S, Frigault MJ, Hunter BD, et al. Blood 2026 Mar 3:blood.2025031733. doi: 10.1182/blood.2025031733.

Read + Share

Amedeo Smart

Independent Medical Education

Crombie JL, Ahmed S, Frigault MJ, Hunter BD, et al. Real-world outcomes for lisocabtagene maraleucel in patients with relapsed or refractory large B-cell lymphoma. Blood 2026 Mar 3:blood.2025031733. doi: 10.1182/blood.2025031733.
PMID: 41774517